Development of modified-release oral tablets of drug products usually requires release-modifying polymers at the level of above 50% of the total weight. This makes the development of high-dose products, especially with doses in the range of 750-1000 mg, difficult because the tablet size becomes unac
Application of melt granulation technology to enhance tabletting properties of poorly compactible high-dose drugs
✍ Scribed by Jay P. Lakshman; James Kowalski; Madhav Vasanthavada; Wei-Qin Tong; Yatindra M. Joshi; Abu T. M. Serajuddin
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 434 KB
- Volume
- 100
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
✦ Synopsis
Using metformin HCl as the model drug and hydroxypropylcellulose (HPC) as the polymeric excipient, a melt granulation (MG) process that employs a twin-screw extruder has been developed to enhance compactibility of poorly compactible high-dose drug substances. A high (90%) drug-load tablet formulation, containing 1025 mg of active pharmaceutical ingredients and 109 mg of excipients, was produced. Drug-polymer-powder mixtures were melt granulated at a temperature above glass transition of HPC (130°C) but below melting point of metformin HCl (224°C). MG was compared with modified wet granulation (WG) and solvent granulation (SG) processes. Under identical compression force, the hardness of tablets produced was MG>SG>WG and the friability was MG
📜 SIMILAR VOLUMES